Lanean...

Single dose oral rofecoxib for acute postoperative pain in adults

BACKGROUND: Editor's note: The anti‐inflammatory drug rofecoxib (Vioxx) was withdrawn from the market at the end of September 2004 after it was shown that long‐term use (greater than 18 months) could increase the risk of heart attack and stroke in a study of secondary prevention of adenoma recu...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Bulley, Simon, Derry, Sheena, Moore, R Andrew, McQuay, Henry J
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley & Sons, Ltd 2009
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4171390/
https://ncbi.nlm.nih.gov/pubmed/19821329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD004604.pub3
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!